Amneal Pharmaceuticals Inc - Ordinary Shares - Class A
AMRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.43B
Close$
$10.20
43.6% downside
Current Fair Value
43.6% downsideOvervalued by 43.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.43 Billion |
|---|---|
| Enterprise Value | $8.10 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.23 |
| Beta | 1.24 |
| Outstanding Shares | 319,200,000 |
Return
| Return on Equity | 288.05% |
|---|---|
| Return on Assets | 2.52% |
| Return on Invested Capital | -7.54% |
Valuation & Multiples
| P/E Ratio | 34.19 |
|---|---|
| PEG | 21.75 |
| Price to Sales | 2.58 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.38 |
| Enterprise Value to EBIT | -37.09 |
| Enterprise Value to Net Income | 85 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | 84.54 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$0.22
Average shareholder expectationRevenue Estimate
$753.54 M
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$0.23
Average shareholder expectationRevenue Estimate
$812.86 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 226.60% |
|---|---|
| Total Calls | 151,300▲ 202.60% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 51.84%▲ 0.93% |
|---|---|
| Total Invested | $2.86B▲ 43.04% |
| Investors Holding | 313▼ 6.00% |
ESG Score
No data